Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

SCIPHER MEDICINE — Lobbying — Receipts Report

LD-2 disclosure · 4th Quarter - Report

SCIPHER MEDICINE

via SCIPHER MEDICINE

4th Quarter (Oct 1 - Dec 31) · 2022Posted Dec 28, 2022Filing document ↗LDA record ↗

Expenses$105Kself-filed spend

Client

Name: SCIPHER MEDICINE
Description: Clinical Laboratory
Location: Massachusetts · United States of America

Registrant

Firm: SCIPHER MEDICINE
Location: Waltham, Massachusetts, United States of America

Lobbying activities

1 issue

Health Issues
Medicare diagnostic test coverage
LobbyistsMATTHEW SIMMONS
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.